BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gong YZ, Zhong XM, Zou JZ. Infliximab treatment of glycogenosis Ib with Crohn's-like enterocolitis: A case report. World J Clin Cases 2021; 9(19): 5280-5286 [PMID: 34307579 DOI: 10.12998/wjcc.v9.i19.5280]
URL: https://www.wjgnet.com/2307-8960/full/v9/i19/5280.htm
Number Citing Articles
1
Yong-Xian Shao, Cui-Li Liang, Ya-Ying Su, Yun-Ting Lin, Zhi-Kun Lu, Rui-Zhu Lin, Zhi-Zi Zhou, Chun-Hua Zeng, Chun-Yan Tao, Zong-Cai Liu, Wen Zhang, Li Liu. Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective studyOrphanet Journal of Rare Diseases 2024; 19(1) doi: 10.1186/s13023-024-03137-6
2
Zhiling Li, Xiaoyan Zhang, Huan Chen, Hanshi Zeng, Jiaxing Wu, Ying Wang, Ni Ma, Jiaoli Lan, Yuxin Zhang, Huilin Niu, Lei Shang, Xun Jiang, Min Yang. Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trialScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59320-z
3
Ersin Gümüş, Hasan Özen. Glycogen storage diseases: An updateWorld Journal of Gastroenterology 2023; 29(25): 3932-3963 doi: 10.3748/wjg.v29.i25.3932
4
Margherita Calia, Andrea Mario Luciano Arosio, Viola Crescitelli, Anna Fornari, Roberta Pretese, Serena Gasperini, Giovanna Zuin. Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case reportTherapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231202138